GFM1
Basic information
Region (hg38): 3:158644527-158695581
Links
Phenotypes
GenCC
Source:
- hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 (Definitive), mode of inheritance: AR
- hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 (Supportive), mode of inheritance: AR
- hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 (Strong), mode of inheritance: AR
- Leigh syndrome (Moderate), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Combined oxidative phosphorylation deficiency 1 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Cardiovascular; Gastrointestinal; Musculoskeletal; Neurologic | 15537906; 17160893; 21119709 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (726 variants)
- Hepatoencephalopathy_due_to_combined_oxidative_phosphorylation_defect_type_1 (262 variants)
- Inborn_genetic_diseases (66 variants)
- not_specified (58 variants)
- GFM1-related_disorder (25 variants)
- See_cases (4 variants)
- Combined_oxidative_phosphorylation_deficiency (3 variants)
- Relative_macrocephaly (1 variants)
- Leigh_syndrome (1 variants)
- Developmental_regression (1 variants)
- Severe_muscular_hypotonia (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GFM1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000024996.7. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 10 | 252 | 265 | |||
missense | 21 | 170 | 23 | 219 | ||
nonsense | 17 | 28 | 46 | |||
start loss | 1 | 1 | ||||
frameshift | 37 | 49 | 87 | |||
splice donor/acceptor (+/-2bp) | 44 | 46 | ||||
Total | 59 | 143 | 182 | 275 | 5 |
Highest pathogenic variant AF is 0.000110293
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GFM1 | protein_coding | protein_coding | ENST00000486715 | 18 | 48298 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
9.28e-13 | 0.993 | 125646 | 0 | 102 | 125748 | 0.000406 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.28 | 339 | 412 | 0.823 | 0.0000213 | 4879 |
Missense in Polyphen | 109 | 151.17 | 0.72104 | 1725 | ||
Synonymous | -0.609 | 151 | 142 | 1.07 | 0.00000713 | 1461 |
Loss of Function | 2.65 | 27 | 46.5 | 0.580 | 0.00000298 | 493 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000735 | 0.000731 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.000272 | 0.000272 |
Finnish | 0.000463 | 0.000462 |
European (Non-Finnish) | 0.000449 | 0.000448 |
Middle Eastern | 0.000272 | 0.000272 |
South Asian | 0.000588 | 0.000588 |
Other | 0.000489 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Mitochondrial GTPase that catalyzes the GTP-dependent ribosomal translocation step during translation elongation. During this step, the ribosome changes from the pre-translocational (PRE) to the post-translocational (POST) state as the newly formed A- site-bound peptidyl-tRNA and P-site-bound deacylated tRNA move to the P and E sites, respectively. Catalyzes the coordinated movement of the two tRNA molecules, the mRNA and conformational changes in the ribosome. Does not mediate the disassembly of ribosomes from messenger RNA at the termination of mitochondrial protein biosynthesis. {ECO:0000255|HAMAP-Rule:MF_03061, ECO:0000269|PubMed:19716793}.;
- Disease
- DISEASE: Combined oxidative phosphorylation deficiency 1 (COXPD1) [MIM:609060]: A mitochondrial disease resulting in early rapidly progressive hepatoencephalopathy. {ECO:0000269|PubMed:15537906, ECO:0000269|PubMed:17160893, ECO:0000269|PubMed:21119709, ECO:0000269|PubMed:26741492}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- miR-targeted genes in epithelium - TarBase;miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase;Translation;Metabolism of proteins;Purine metabolism;Mitochondrial translation elongation;Mitochondrial translation
(Consensus)
Recessive Scores
- pRec
- 0.162
Intolerance Scores
- loftool
- 0.836
- rvis_EVS
- 0.62
- rvis_percentile_EVS
- 83.47
Haploinsufficiency Scores
- pHI
- 0.0969
- hipred
- N
- hipred_score
- 0.463
- ghis
- 0.533
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.408
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gfm1
- Phenotype
- homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- mitochondrial translational elongation
- Cellular component
- mitochondrion;mitochondrial matrix
- Molecular function
- RNA binding;translation elongation factor activity;GTPase activity;protein binding;GTP binding